PDF Cover

Ligation Devices Market

The market for Ligation Devices was estimated at $1.4 billion in 2025; it is anticipated to increase to $2.1 billion by 2030, with projections indicating growth to around $3.0 billion by 2035.

Report ID:DS1801045
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Ligation Devices
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Ligation Devices Market Outlook

Revenue, 2025

$1.4B

Forecast, 2035

$3.0B

CAGR, 2026 - 2035

7.5%

The Ligation Devices industry revenue is expected to be around $1.4 billion in 2026 and expected to showcase growth with 7.5% CAGR between 2026 and 2035. The increasing focus on the use of haemostatic agents in surgical procedures reflects the growing interest in devices that enhance surgical care. These devices allow for quicker procedures and less post operative complications. Effective haemostasis is also becoming a key consideration. With rising levels of minimally invasive surgery taking place, a growing number of gastrointestinal and oncological conditions and better surgical tool technology driving precision are behind the increasing demand. In 2025, minimally invasive surgical products generated $0.93 billion, and were the leading revenue source within the market segment. This is due to the high level of preference amongst surgeons for the clinical and economic benefits offered by laparoscopic and endoscopic ligation systems. Surgical Specialties, including Gastrointestinal & Abdominal Surgery and other surgical region's, account for 52% of the total application in this market. This shows how important theses of surgery are in how hospitals and clinics decide to purchase medical equipment and highlights how essential advanced ligation devices are in hospitals and clinics.

A range of mechanical and energy assisted ligating instruments are used, including endoscopic ligating clips, banding systems and laparoscopic instruments as well as ligation devices for major blood vessels. These are designed to cut off and seal various structures including blood vessels and ducts in the body with minimal blood loss. In surgery of the abdomen and intestines, the laparoscopic tools are highly valued; so too in gynaecology, urology and similar operations where minimal bleeding and a fast treatment are of prime importance. Minimally invasive surgery has seen an increase in the production of ergonomically designed endoscopic ligation tools. Additionally there is a rising use of single use and reposable ligation tools which can assist in infection control and also help save costs. There is also greater integration with advanced imaging and energy technology to improve the accuracy of surgical interventions. The various improvements in Ligation Devices are resulting in their wider use in the medical sector and in sustained order inflows for both surgical procedures and more intricate interventions.

Ligation Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035
Ligation Devices Market Outlook

Market Key Insights

  • The Ligation Devices market is projected to grow from $1.4 billion in 2025 to $3.0 billion in 2035. This represents a CAGR of 7.5%, reflecting rising demand across Surgical Procedure, Laparoscopic, and Gynecological Treatments.

  • Top vendors in the electrosurgical market are Medtronic, Johnson & Johnson Services Inc., and CONMED Corporation, whose influence is felt across the competitive landscape of the industry.

  • The United States and Germany are expected to dominate the Ligature Devices market and exhibit compound annual growth rates of 7.2% to 4.9% from 2030 to 2025 respectively.

  • The fastest growing markets will be the emerging economies of India, Mexico and Brazil, which are likely to see growth of between 8.6% and 10.3% per year.

  • The impact of digital revolution in the ligation devices industry is predicted to result in an extra $161 million in annual revenue by the year 2030.

  • Between 2025 and 2035, the market for ligation devices is forecast to increase by $1.5 billion. Its biggest growth region is expected to be in cardiothoracic surgery applications and in gynaecological surgery.

  • As diseases are becoming more widespread and ligation technology improves continuously, the market for ligation devices is anticipated to grow by 106% between 2025 and 2035.

ligation devices market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Ligation Devices - Country Share Analysis

Opportunities in the Ligation Devices

The shift in outpatient procedures from hospitals to ambulatory surgical centers in the United States offers considerable opportunity for cost effective Ligation Devices. A number of hospitals and ASCs are also choosing reusable clip applicators along with ergonomic clip appliers and suitable accessories. Globally, medical accessories are predicted to rise from 0.31 to 0.38 billion by a compound rate of 4.2%. Systems of advanced surgical and medical instruments that are used in laparoscopic surgery are however expected to increase more. This growth will be driven by preference from surgeons for equipment to stop bleeding.

Growth Opportunities in North America and Asia Pacific

In North America the biggest market for ligation devices exists in cardiothoracic and gastrointestinal abdominal surgeries, where minimally invasive surgical procedures and stringent haemostasis standards are increasingly making surgeons dependent on high tech ligation instruments and vessel sealing equipment. Key product region's include premium energy integrated ligation devices designed for high acuity cardiothoracic centres, procedure kits for bariatric and colorectal surgery used in large healthcare systems, and a single use endoscopic ligation product line which is optimised for use in ambulatory surgery centres where value based pricing is used. Though a strong influence is exerted on competitive dynamics by the multinational brands which have entrenched themselves, regional innovators and their OEM partners are steadily increasing their market share. This is due to a range of factors, including product customisation. Market drivers in the disposable ligation clip business include the adoption of stricter hospital protocols to reduce the risk of infection and the consolidation of hospitals which necessitates standardised clip products. In addition, the health care reimbursement environment favours minimally invasive procedures.
In the Asia Pacific region, the use of ligation devices is primarily driven by procedures in the fields of gynaecology and abdominal/gastrointestinal surgery. Laparoscopic procedures in hospitals are also on the rise. The greatest potential opportunities appear to be found in the development of cost effective yet reliable surgical ligation instruments which can be sold to public authorities via competitive bidding processes. Another region with considerable growth potential is in the production of equipment sets used in procedures that are performed through small incisions in the abdomen. A further region is gynaecology focused endoscopic instruments which are customised as per the requirements of local clinical treatment and the training which is available. Currently there is a fragmented market with local firms competing mainly on price whilst global suppliers focus primarily on high end hospitals in urban region's. This leaves the mid tier market open for companies that provide quality Ligation Devices and cater to regional needs through services and training as well as flexible payment options. Factors that contribute to the growth of the regional market include government funded investments in surgical equipment, increased access by the growing middle class to surgical operations and the production of products that use minimally invasive surgical techniques. Additionally the government provides incentives to local manufacturers who produce haemostasis products within the region.

Market Dynamics and Supply Chain

01

Driver: Rising Adoption of Minimally Invasive Surgeries and Increasing Surgical Procedure Volumes

The ligation devices market is also significantly driven by the growing preference for minimally invasive surgeries and the overall rise in surgical procedures worldwide. Minimally invasive techniques such as laparoscopy and endoscopic surgeries demand specialized ligation tools, including clip appliers and vessel sealers, to operate within small incisions while maintaining hemostasis. This trend reduces patient recovery time, lowers complication rates, and enhances procedural efficiency, boosting device adoption. Simultaneously, the global increase in surgical volumes, driven by aging populations, rising incidence of chronic conditions, and expanding hospital infrastructure, expands the addressable market for ligation devices. Hospitals and surgical centers are also increasingly investing in advanced ligation solutions to meet growing procedural demand while improving clinical outcomes. These combined factors are also accelerating sales of ergonomic, reliable, and energy‑based ligation devices across general surgery, gynecology, and other specialty areas. 
Technological advancements represent a key market driver, particularly energy-based ligation systems and ergonomic device designs that improve surgical efficiency and safety. Energy-based vessel sealers enable rapid, reliable closure of blood vessels and tissue with minimal thermal spread, reducing intraoperative blood loss. Ergonomically designed clip appliers and handheld ligation instruments enhance surgeon comfort, precision, and control during prolonged procedures. These innovations support faster operative times, improved patient outcomes, and increased adoption of advanced ligation devices in hospitals and specialty clinics worldwide.
02

Restraint: High Device Costs and Reimbursement Limitations Restrict Adoption in Smaller Healthcare Facilities

Ligation devices, especially advanced energy‑based and single‑use systems, often come with high purchase and operational costs that can deter budget‑constrained hospitals and clinics from upgrading or adopting them. Limited reimbursement policies in certain regions further discourage investment in premium devices, leading facilities to rely on traditional sutures or reusable tools. This cost barrier suppresses demand, slows revenue growth for manufacturers, and limits market penetration in emerging and resource‑limited healthcare settings.
03

Opportunity: Growing oncology and gynecology surgery volumes in Latin America accelerate premium Ligation Devices penetration and Rising minimally invasive gastrointestinal surgery in India unlocks demand for advanced endoscopic Ligation Devices

There are large, untapped markets for ligation devices in the region of oncology and gynaecology within Latin America. This is due to the expansion of both public and private oncology and gynecology services. There has been a rise in healthcare insurance coverage in Brazil, Mexico and Chile. This rise has generated an increased requirement for precise surgical ligation in cancer and hysterectomy treatments. The global sub segment of ligation instruments, which is characterised by its agility, has seen its market rise from 0.20 billion to 0.35 billion at a CAGR of 11.49%.It is expected that the premium products and specialised accessories for the region which require training and maintenance, would have the highest growth rate.
There is a growing need in Indian hospitals for the sort of medical equipment known as ligation devices, this is particularly so in large teaching hospitals and in centres providing day care. This is partly due to the rising incidence of conditions including obesity and colorectal cancer, also gastrointestinal bleeding. The demand is particularly strong for single use haemostasis instruments and endoscopic ligation equipment which support minimally invasive surgery techniques. Growth in global endoscopic ligator sales, from 93 million dollars in 2012 to 134 million by 2030, is anticipated to be eclipsed by that of ligation for gastrointestinal uses in India. This is especially true for rapidly urbanising Tier 2 and Tier 3 cities.
04

Challenge: Concerns Over Surgical Training and Operator Skill Affect Device Utilization Rates

Effective use of advanced ligation devices requires trained surgeons and support staff, but many facilities face gaps in specialized training for new technologies. Inadequately trained teams may underutilize devices, revert to conventional methods, or experience procedural delays, which impacts clinical outcomes and dampens hospital confidence in purchasing newer systems. This skill gap restrains market growth by reducing device throughput, slowing adoption, and diminishing return on investment for healthcare providers.

Supply Chain Landscape

1

Raw Material Supply

3M Health CareDSM BiomedicalCovestro
2

Ligation Devices Manufacturing

MedtronicJohnson & Johnson Services Inc.B. Braun SE
3

Medical Device Distribution

Cardinal HealthOwens & MinorMcKesson
4

Clinical End Users

HospitalsAmbulatory Surgical CentersSpecialty Clinics
Ligation Devices - Supply Chain

Use Cases of Ligation Devices in Surgical Procedure & Gynecological Treatments

Surgical Procedure : In general surgical procedures, ligation devices such as clip appliers, vessel sealing instruments, and band ligators are widely used to securely tie off blood vessels and ducts to control bleeding and improve operative safety. These tools are essential in both open and minimally invasive surgeries performed in hospitals and surgical centers, ensuring precise vessel closure with reduced operative time and blood loss. Major providers like Ethicon (Johnson & Johnson), Medtronic, Teleflex, and B. Braun lead this segment with robust portfolios of handheld ligation devices, energy‑based sealers, and accessories that enhance procedural efficiency and clinical outcomes. Their strong research and development support and global distribution networks reinforce their leadership in supplying reliable ligation solutions for diverse surgical specialties.
Laparoscopic : In laparoscopic surgeries, specialized endoscopic ligation devices and clip appliers facilitate vessel sealing and tissue ligation within confined surgical spaces, enabling surgeons to perform complex procedures through small incisions. These devices are especially valuable in abdominal operations where precise control of bleeding and tissue management directly impacts recovery and complication rates. The growing adoption of minimally invasive surgery (MIS) has fueled demand for ergonomic, reliable ligation tools that deliver quick and consistent performance during laparoscopy. Providers like Olympus, Applied Medical, and ConMed are notable for their laparoscopic ligation offerings, combining advanced device design with high clinical utility.
Gynecological Treatments : In gynecological treatments, ligation devices play a crucial role in procedures such as hysterectomy, tubal ligation, and pelvic surgery, where secure vessel and tissue closure is paramount. Endoscopic ligation clips and energy-based sealers help reduce intraoperative blood loss, decrease operative time, and support faster patient recovery. The use of these devices in gynecology has expanded with rising surgical volumes and preference for minimally invasive approaches. Key companies like Cooper Surgical, Teleflex, and Ethicon provide a range of ligation solutions tailored to gynecologic interventions, supported by clinical evidence and widespread adoption in hospitals and specialist clinics worldwide.

Recent Developments

The ligation devices market is seeing rapid innovation with energy‑based vessel sealers, advanced clip appliers, and minimally invasive surgical tools gaining traction across laparoscopic, general, and gynecological procedures. A key trend is integration of ergonomic design and improved hemostatic control to reduce operative time and blood loss. Leading manufacturers are expanding surgeon training programs, enhancing device compatibility with robotic systems, and focusing on single‑use ligation instruments to meet rising demand for efficiency, safety, and infection control in modern surgery.

July 2025 : Medtronic received CE Mark approval for its LigaSure™ vessel‑sealing technology integrated with the Hugo robotic surgery system in Europe, expanding its use in general, gynecologic, and urologic procedures.
June 2025 : Teleflex Hem‑o‑lok® ligating clips multiple polymer clips received FDA 510(k) clearance, enhancing its clip offerings for vessel/tissue ligation procedures.
December 2024 : Applied Medical Resources Corporation launched a new ligation system designed for improved safety and efficiency in laparoscopic procedures in North America and Europe.

Impact of Industry Transitions on the Ligation Devices Market

As a core segment of the Medical Device industry, the Ligation Devices market develops in line with broader industry shifts. Over recent years, transitions such as Digital Revolution in Ligating Devices and Sharpening Focus on Minimally Invasive Solutions have redefined priorities across the Medical Device sector, influencing how the Ligation Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Digital Revolution in Ligating Devices

The trend towards the digital and connected ligation devices is driving change in surgery, as ligation systems that are intelligent and integrated surgical tools replace the traditional, stand alone instruments which were operated manually in a wide range of procedures. Smart surgical tools, featuring connectivity, sensors and analytics, have been introduced into ligation instruments and other surgical equipment by hospitals. By doing so, they have improved the efficiency of the operating room, optimised the workflow of operations and achieved consistency in patient care results. Digital surgery is driving change in how surgeons and their teams plan, execute and document procedures, as well as generating opportunities for those vendors who can provide data rich systems which communicate effectively with other medical equipment. The global ligation devices market will be impacted by the Digital Revolution in ligation devices technology, this is forecast to give rise to around $161 million in market growth by the year 2030. This positioning of the device as a main engine for growth for the industry and for reducing the long term costs of healthcare is key.
02

Sharpening Focus on Minimally Invasive Solutions

The growing preference for minimally invasive procedures has significantly reshaped the ligation devices market. Patients increasingly favor less invasive treatments due to reduced pain, faster recovery, and lower complication risks, prompting hospitals and surgical centers to adopt advanced ligation tools like laparoscopic clip appliers and energy-based vessel sealers. Pharmaceutical and medical device companies are investing heavily in research and development to optimize these devices for minimally invasive applications. This shift has positively impacted associated industries, including general surgery, gynecology, and bariatric surgery, by enabling shorter hospital stays, higher patient throughput, and improved clinical outcomes. Companies such as Ethicon, Medtronic, and Olympus are leveraging these trends to develop ergonomic, precision-engineered devices that enhance procedural efficiency and support the growing demand for minimally invasive interventions across global healthcare markets.